Trinity Biotech Revenue and Competitors

Bray, IE

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Trinity Biotech's estimated annual revenue is currently $106.2M per year.(i)
  • Trinity Biotech's estimated revenue per employee is $236,548
  • Trinity Biotech's current valuation is $28.9M. (January 2022)

Employee Data

  • Trinity Biotech has 449 Employees.(i)
  • Trinity Biotech grew their employee count by -1% last year.

Trinity Biotech's People

NameTitleEmail/Phone
1
SVP Global Sales & General Manager North AmericaReveal Email/Phone
2
Director and CSOReveal Email/Phone
3
Director Operations Autoimmune Division (Immco)Reveal Email/Phone
4
Director OperationsReveal Email/Phone
5
Operations ManagerReveal Email/Phone
6
Quality System & Regulatory ManagerReveal Email/Phone
7
Quality Assurance ManagerReveal Email/Phone
8
Quality ManagerReveal Email/Phone
9
Software Engineering ManagerReveal Email/Phone
10
Shipping and Facilities ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24.8M994%N/AN/A
#2
$31.9M12712%N/AN/A
#3
$51M20310%N/AN/A
#4
$38.4M15312%N/AN/A
#5
$26.6M106-6%N/AN/A
#6
$32.4M1296%N/AN/A
#7
$24.8M991%N/AN/A
#8
$26.6M1061%N/AN/A
#9
$34.6M1382%N/AN/A
#10
$65.5M2611%N/AN/A
Add Company

What Is Trinity Biotech?

Since its formation in 1992, Trinity Biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. Through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products. The test kits manufactured by Trinity Biotech are used in the clinical laboratory and point-of-care segments of the diagnostic market to detect infectious diseases, sexually transmitted diseases, autoimmune and haemoglobin disorders, and detect, monitor and control diabetes. The company is also a significant provider of raw materials to the life sciences industry. Trinity Biotech, which has its headquarters in Ireland, employs in excess of 350 people and markets its portfolio of over 400 products to customers in 80 countries around the world. It reaches this worldwide market by combining the skills of its own sales force with a network of international distributors and strategic partners. Trinity Biotech has manufacturing facilities in: Bray, Ireland - Rapids, Infectious Disease Carlsbad , USA — Infectious Disease — Western Blot, Point-of-care development Acton , USA — Raw materials for supply to the research and diagnostic industries Jamestown , USA — Infectious Disease — Enzyme Immunoassay (EIA) Kansas City , USA —Diabetes Diagnostics based on Boronate Affinity HPLC Infectious Disease Diagnostics, Point of Care Diagnostics, Haemoglobins, Clinical Chemistry

keywords:N/A

N/A

Total Funding

449

Number of Employees

$106.2M

Revenue (est)

-1%

Employee Growth %

$28.9M

Valuation

N/A

Accelerator

Trinity Biotech News

2022-04-20 - Trinity Biotech plc (NASDAQ:TRIB) Short Interest Update

Trinity Biotech had a negative return on equity of 27,745.46% and a net margin of 0.94%. Several hedge funds and other institutional investors...

2022-04-06 - Trinity Biotech Announces A $45 Million Strategic Investment ...

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity...

2022-04-06 - Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 ...

Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-...